During 2014, a subclade 2.3.4.4 highly pathogenic avian influenza (HPAI) A(H5N8) virus caused poultry outbreaks around the world. In late 2014/early 2015, the virus was detected in wild birds in Canada and the United States, and these viruses also gave rise to reassortant progeny, composed of viral RNA segments (vRNAs) from both Eurasian and North American lineages. In particular, viruses were found with N1, N2, and N8 neuraminidase vRNAs, and these are collectively referred to as H5Nx viruses. In the United States, more than 48 million domestic birds have been affected. Here we present a detailed structural and biochemical analysis of the surface antigens of H5N1, H5N2, and H5N8 viruses in addition to those of a recent human H5N6 virus. Our results with recombinant hemagglutinin reveal that these viruses have a strict avian receptor binding preference, while recombinantly expressed neuraminidases are sensitive to FDA-approved and investigational antivirals. Although H5Nx viruses currently pose a low risk to humans, it is important to maintain surveillance of these circulating viruses and to continually assess future changes that may increase their pandemic potential.
IMPORTANCEThe H5Nx viruses emerging in North America, Europe, and Asia pose a great public health concern. Here we report a molecular and structural study of the major surface proteins of several H5Nx influenza viruses. Our results improve the understanding of these new viruses and provide important information on their receptor preferences and susceptibilities to antivirals, which are central to pandemic risk assessment.
Influenza A viruses are encoded by eight segments of negativesense RNA (vRNAs), which enable rapid evolution via an errorprone RNA-dependent RNA polymerase and gene transfer by reassortment of vRNAs during coinfections. Human infections with zoonotic influenza A virus subtypes continue to be a global concern. A highly pathogenic avian influenza (HPAI) A(H5N1) virus caused its first human infection in Hong Kong in 1997 (1). To date, more than 800 human cases in 16 countries, with an overall fatality rate of 53%, have been reported since 2003 (2). The H5 hemagglutinin (HA) vRNA continues to evolve into diverse clades and subclades (3, 4). In early 2014, a novel subtype of HPAI A(H5N8) virus of subclade 2.3.4.4 caused poultry outbreaks in South Korea and subsequently spread to China, Japan, the Russian Federation, and Europe. Another novel HPAI A(H5N6) virus subtype of the same H5 subclade caused multiple outbreaks in Southeast Asia and resulted in one fatal human infection in China in April 2014 (5).At the end of 2014, commercial turkey farms in southern British Columbia, Canada, reported increased mortality in their flocks. Subsequent investigation revealed the presence of an HPAI A(H5N2) virus containing five Eurasian-lineage vRNA segments of A(H5N8) origin and three vRNA segments from North American-lineage viruses (6). During this time, U.S. authorities also detected an HPAI A(H5N2) virus (northern pintail/Washington/ 40...